- Home
- IPHA vs DUOT Comparison
IPHA vs DUOT Comparison
Compare IPHA & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- DUOT
- Stock Information
- Founded
- IPHA 1999
- DUOT 1990
- Country
- IPHA France
- DUOT United States
- Employees
- IPHA N/A
- DUOT N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- DUOT Computer Software: Prepackaged Software
- Sector
- IPHA Health Care
- DUOT Technology
- Exchange
- IPHA Nasdaq
- DUOT Nasdaq
- Market Cap
- IPHA 160.1M
- DUOT 169.7M
- IPO Year
- IPHA 2019
- DUOT N/A
- Fundamental
- Price
- IPHA $2.18
- DUOT $9.50
- Analyst Decision
- IPHA Hold
- DUOT Strong Buy
- Analyst Count
- IPHA 2
- DUOT 2
- Target Price
- IPHA $2.00
- DUOT $12.75
- AVG Volume (30 Days)
- IPHA 12.3K
- DUOT 296.3K
- Earning Date
- IPHA 09-17-2025
- DUOT 11-18-2025
- Dividend Yield
- IPHA N/A
- DUOT N/A
- EPS Growth
- IPHA N/A
- DUOT N/A
- EPS
- IPHA N/A
- DUOT N/A
- Revenue
- IPHA $14,839,695.00
- DUOT $15,387,935.00
- Revenue This Year
- IPHA $50.89
- DUOT $292.26
- Revenue Next Year
- IPHA N/A
- DUOT $43.21
- P/E Ratio
- IPHA N/A
- DUOT N/A
- Revenue Growth
- IPHA N/A
- DUOT 172.93
- 52 Week Low
- IPHA $1.29
- DUOT $3.71
- 52 Week High
- IPHA $3.51
- DUOT $9.60
- Technical
- Relative Strength Index (RSI)
- IPHA 60.94
- DUOT 66.70
- Support Level
- IPHA $2.07
- DUOT $7.70
- Resistance Level
- IPHA $2.28
- DUOT $8.70
- Average True Range (ATR)
- IPHA 0.09
- DUOT 0.59
- MACD
- IPHA 0.01
- DUOT 0.05
- Stochastic Oscillator
- IPHA 69.70
- DUOT 91.32
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.